Overview
Phesgo is a combination prescription drug approved by the U.S. Food and Drug Administration (FDA) for use with chemotherapy to treat adults with early-stage HER-2 positive breast cancer. Phesgo is also approved… read more
Overview
Keytruda Qlex is approved by the U.S. Food and Drug Administration (FDA) for the treatment of certain forms of triple-negative breast cancer (TNBC). It is approved for adults with high-risk early-stage TNBC in…